Navigation Links
cardiometabolic in Medical News

CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals

More than 1,500 CME Sessions Viewed at www.CardioCareLive.com , Now Available On-Demand Through June 2009 Boston, MA (PRWEB) April 2, 2009 -- CardioCareLive.com, the inaugural online medical conference for physicians and healthcare professionals working with patients w...

CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today

Virtual Medical Event Available from the Convenience of a Computer www.CardioCareLive.com takes place entirely online Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak. To ...

Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference

Online-Only Event Brings Together Leading Cardiovascular Experts LAS VEGAS, Feb. 24 /PRNewswire/ -- Noninvasive Medical Technologies, Inc. (NMT), an award-winning company engaged in pioneering highly advanced remote patient monitoring solutions, today announced that the Company will be showca...

Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned

Additional beneficial effects on cardiometabolic risk factors beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an article in the June issue of Drug and Therapeutics Bulletin (DTB). Advertisements for rimonabant ...

FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

...rapeutic option to a large, competitive market for cardiometabolic disorders," said Ben Stakely, CEO and President, K...h KPA's long-term vision to become a leader in the cardiometabolic therapeutic arena. Since its launch in Japa...aceutical company focused primarily in the area of cardiometabolic therapeutic area. The company, started in 2001 as ...

-Contrave(R) Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-

...OCF) of all randomized patients who had at least one post-baseline observation while on study drug. Secondary endpoints included multiple measures of cardiometabolic risk, food cravings and eating control, as well as HbA1c in the COR Diabetes trial. Patients were randomized to receive either placebo or Contrave, B...

Independence Blue Cross Expands Its Preventive Health Efforts With Focus on Heart Disease and Diabetes

...gram targets members who are at risk of developing cardiometabolic syndrome, a condition which may increase a person'...g, serious and costly health conditions." The cardiometabolic Risk Management Program teaches members about thei...these diseases and help them lead healthier lives. cardiometabolic risk factors that increase a person's overall chan...

VAP(R) Cholesterol Test Highlighted in Groundbreaking Book on Longevity

...information call 877.901.8510 or visit www.thevaptest.com . About Atherotech, Inc. Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP ...

Genomas Presents Drug-Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis

...d Hospital (Hartford, CT) and the University of California, San Francisco . Researchers genotyped 384 SNPs (single nucleotide polymorphisms) from 222 cardiometabolic and neuroendocrine genes with a potential role in determining the safety and efficacy of statins. The study was funded in part by a grant from the Nat...

New Research Suggests Strong Link Between Sweetened Caloric Beverages and Metabolic Syndrome

...hop, which is hosted by the International Chair on cardiometabolic Risk (ICCR). Dr. Jean-Pierre Despres, Universite L... disease." About the International Chair on cardiometabolic Risk Based at Universite Laval in Quebec City, ... Its goal is to enhance awareness and knowledge of cardiometabolic risk factors in order to improve international pat...
cardiometabolic in Medical Technology

Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat

QUEBEC CITY, Canada, April 29 /PRNewswire/ -- At a late breaking presentation made on April 29th during the Annual meeting of the European Atherosclerosis Society held in Istanbul, the investigators of ADAGIO-LIPIDS presented the key findings of a one year trial aiming at further studying the ...

Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity

... "The weight loss seen across our phase 2 and phase 3 obesity and diabetes Qnexa trials to date, coupled with the positive impact observed on other cardiometabolic factors such as blood pressure, cholesterol and glucose, is impressive and potentially represents a step forward in the treatment of obesity and obesi...

Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis

...ents with cancer (Erbitux(R), cetuximab), multiple sclerosis (Rebif(R), interferon beta-1a), infertility (Gonal-f(R), follitropin alfa), endocrine and cardiometabolic disorders (Glucophage(R), metformin); (Concor(R), bisoprolol); (Euthyrox(R), levothyroxine); (Saizen(R) and Serostim(R), somatropin). Not all products...

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

...ents with cancer (Erbitux(R), cetuximab), multiple sclerosis (Rebif(R), interferon beta-1a), infertility (Gonal-f(R), follitropin alfa), endocrine and cardiometabolic disorders (Glucophage(R), metformin); (Concor(R), bisoprolol); (Euthyrox(R), levothyroxine); (Saizen(R) and Serostim(R), somatropin). Not all products...

Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial

...ents with cancer (Erbitux(R), cetuximab), multiple sclerosis (Rebif(R), interferon beta-1a), infertility (Gonal-f(R), follitropin alfa), endocrine and cardiometabolic disorders (Glucophage(R), metformin); (Concor(R), bisoprolol); (Euthyrox(R), levothyroxine); (Saizen(R) and Serostim(R), somatropin). Not all products...

Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis

...o. Merck Serono has leading brands serving patients with cancer (Erbitux(R)), multiple sclerosis (Rebif(R)), infertility (Gonal-f(R)), endocrine and cardiometabolic disorders (Glucophage(R), Concor(R), Euthyrox(R), Saizen(R), Serostim(R)), as well as psoriasis (Raptiva(R)). With an annual R&D expenditure of arou...

Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis

...o. Merck Serono has leading brands serving patients with cancer (Erbitux(R)), multiple sclerosis (Rebif(R)), infertility (Gonal-f(R)), endocrine and cardiometabolic disorders (Glucophage(R), Concor(R), Euthyrox(R), Saizen(R), Serostim(R)), as well as psoriasis (Raptiva(R)). With an annual R&D expenditure of arou...

Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b

...elopment of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development is cardiometabolic diseases, including therapies for thrombosis, dyslipidemia, hypertension, diabetes, and acute coronary syndromes. Equally important to the company is ...

Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds

...f Cardiology Foundation recently published a consensus statement that recommends physicians use ApoB measurements to guide therapy in individuals with cardiometabolic risk who are on statin therapy(2). Yet, clinically available methods of measuring lipoprotein particle subpopulations are not standardized and general...

Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening

...ations where conventional blood collection is simply not available. ZRT's cardiometabolic Profile tests key biomarkers including triglycerides, insulin, hemoglobin A...veloping type 2 diabetes and/or cardiovascular disease. In addition to this cardiometabolic risk testing, ZRT offers simple blood spot tests for a wide range of hormon...
cardiometabolic in Biological News

LDL particle measurement by NMR recognized by ADA, ACC

...(NMR) is one of the more accurate ways to evaluate cardiometabolic risk (CMR). The study, published in the April iss...patients risk for cardiovascular disease (CVD). cardiometabolic Risk (CMR) is associated with Type 2 Diabetes and ...characterizes lipid abnormalities in patients with cardiometabolic risk," says Robert S. Rosenson, MD, Director of Li...
cardiometabolic in Biological Technology

Atherotech Unveils New Cardiometabolic Test Panels

Heart disease and diabetes markers to complement VAP advanced cholesterol profile ORLANDO, Fla. and BIRMINGHAM, Ala., March 30 /PRNewswire/ -- Atherotech, Inc., developer of the VAP Cholesterol Test, has announced the addition of new cardiovascular and metabolic testing panels at ACC.09, the ...

CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases

PALO ALTO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that the company has enrolled the first patient in a Phase 1 trial of CVT-3619, a novel oral compound for potential treatment of cardiometabolic diseases. The U.S. Food and Drug Administ...

Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer

...alth care professionals about Atherotech's line of cardiometabolic tests. He'll also be responsible for furthering un...ssment of patients at intermediate to high risk of cardiometabolic diseases. Atherotech continues to add advanced and...erotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Choles...

VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ

...lete our clinical trials of VIA-2291 on expected timetables and the outcomes of such clinical trials; complexities in designing and implementing cardiometabolic clinical trials using surrogate endpoints in Phase 1 and Phase 2 clinical trials which may differ from the ultimate endpoints required for registratio...

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

...atients treated with Contrave versus placebo (p< 0.01), as well as previously reported results on the primary weight loss endpoints and measures of cardiometabolic risk. "NB-302 results show that Contrave initiates and sustains weight loss and can improve predictive markers for heart disease such as waist circum...

Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings

... Roosevelt Hospital Center, New York, N.Y. Title: "Combination Therapy with Naltrexone + Bupropion Causes Significant Weight Loss and Improves cardiometabolic Parameters in Obese Individuals: A Randomized Phase 3 Study Over 56 Weeks" Time: 11:15 a.m. ET Location: Room 152AB About Orexige...

Atherotech Receives Patent for ApoB Measurement

...information call 877.901.8510 or visit www.thevaptest.com . About Atherotech, Inc. Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP ...

VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)

...t or the partnership, please visit www.anylabtestnow.com/VAP . About Atherotech, Inc. Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP ...

Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia

...ion of more than a dozen tests for patients at intermediate to high risk of cardiometabolic diseases. The new test panels are available immediately and also include ho... Atherotech, Inc. Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports...

Merck Serono Launches Strategic Venture Capital Fund

...ents with cancer (Erbitux(R), cetuximab), multiple sclerosis (Rebif(R), interferon beta-1a), infertility (Gonal-f(R), follitropin alfa), endocrine and cardiometabolic disorders (Glucophage(R), metformin); (Concor(R), bisoprolol); (Euthyrox(R), levothyroxine); (Saizen(R) and Serostim(R), somatropin). Not all products...
Other Tags
(Date:7/2/2015)... ... July 02, 2015 , ... ... their products, services, channels and business models. To help manage the increasing demand ... addition of Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a ...
(Date:7/1/2015)... ... 2015 , ... In the United States, summer has always been the season ... Arabia and Dubai, the summer temperatures are so hot, that July vacationers often leave ... Saleh of ORA Dentistry Spa notes that a trip to the United States, and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. ... Georgia State University and a Georgia Research Alliance Eminent Scholar in Inflammation and ... therapeutics against middle-ear infections. , The grant from the National Institute on Deafness ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court overseeing a ... has granted the Defendants’ Motion for Summary Judgment. According to an Order issued ... the Court rejected the Plaintiff’s assertion that one manufacturer can be held ...
(Date:7/1/2015)... ... July 01, 2015 , ... There ... liberty. Americans have been arguing over laws governing sexuality since the first Pilgrims ... a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker ...
Breaking Medicine News(10 mins):Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4
(Date:6/17/2015)... und GERMANTOWN, Maryland , June 17, ... ®   Produktlinie mit DNA-Tests verbessert den Analyseprozess ... QGEN ; Frankfurt Prime Standard: QIA) hat heute ... der Produktlinie Investigator ® ... eingeführt. Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten ...
(Date:6/16/2015)... YORK , June 16, 2015  With the ... world, security remains a top concern. The recent compromise ... confirms the need for strong authentication within government agencies. ... Token, a biometric one-time password (OTP) authenticator, has been ... Standards (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces that its ... showcased to media at Digital Experience! @ NYC June 18th. ... showcase of the latest innovation in technology to over 300 ... be held at the Metropolitan Pavilion in New ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
Other Contents